Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
It certainly matters if Zhabilov had another public entity that was suspended for making false medical claims, especially since it is the same patent (IPF) that is used to help the human body fight cancer, HIV, and Ebola.
Folks who are either ignorant or want to drive the price down want us to think Zhabilov was, in the opinion of the SEC, attempting to defraud people. That is not the case.
It is easy to read the SEC documents related to the case. The suspension has nothing to do with claims about Ebola.
No Adam- you are incorrect. The SEC suspended trading for IMMB for a very specific reason. The PR released by IMMB stated that they would do being with an entity that was an empty shell. The shell was owned by one of Zhabilov's Bulgarian friends that had many contacts in the African hospital systems. The idea was that Zhabilov's friend would introduce the immunotherapy treatment (which also works for Ebola) to the hospitals.
The SEC ruled that corporations and people are separate entities and that the PR violated a rule because IMMB was releasing a PR about doing business with an empty shell company.
This is a classic case of overzealous prosecution and government overreach. Zhabilov and his African friend could have actually helped people but some nitwit at the SEC decided that a minor prosecutorial feather in his cap was worth more than the health of Ebola victims. The SEC used a technicality that should not be applied to this situation because the intent was not to defraud.
The intent was to help people and make money for IMMB investors, and the IMMB investors got hosed.
You should read the SEC statements about this case before you post about this subject again, imo.
Acquisition news?? Asquisition of what? How?
ACTL has nothing to offer but debt to a potential partner. I don't have to go out very far on the proverbial limb by saying there will be no acquistion involving ACTL. That makes zero financial sense.
The correct term is "83 MILLY" $$$$$$.
The 3 billion A/S is not "my figure"! It comes straight from the company in the 10k.
With all due respect, it is my opinion that the CEO of Artec is telling you as plain as day to expect dilution up to 3 billion shares. Without the dilution, according to the 10k, Artec can't survive.
Good point. He is closely watching the company resources (he can see his $29,000 online when he logs in to his bank account).
ACTL is a guy working by himself out of his house and he clearly stated in the 10k that the ONLY way for the company to survive is to dilute the shareholders. RUN! imo.
You think this company is worth 75 million dollars? ACTL owns no real estate, ACTL can't survive without diluting the shareholders because they are bleeding cash, and ACTL has less money in the bank than the vast majority of traders on IHUB.
10 cents a share is an incredibly irresponsible thing to write imo.
Did you read the 10k? ACTL, a company operated out of the house of a the CEO, can't survive without dilution and the 10k states that a raise to a 3 billion AS is coming. How is that a good thing?
The 10k clearly states that a 3 billion A/S is on the horizon and probable.
The CEO also clearly states that he will have to dilute to survive.
This 10k is horrible to read for investors.
Acquisition??? Why on Earth would anybody acquire ACTL? You can go buy a clean shell for 50k. Why take on all this debt? I have more cash in my closet safe than ACTL has. Who would want this company and why?
I would love to hear your response.
Remember the "83 milly float"? LOL, that was only 1/8th of the truth.
No wonder ACTL would not call me back. This business is home based and is bleeding cash.
There is nobody to answer the phone because there is one employee. Wow. How can this guy be allowed to sell shares for this nonsense? This is one of the silliest 10k I have ever read.
The CEO says clearly that he can't survive without diluting the current shareholder base. There are no assets to acquire, only debt, so there is no way somebody would acquire this shell. I now feel bad for the folks stuck in this one.
No, you are wrong. It is not a drug. All you would need to do is go to Zhabilov's website and read for 60 seconds to understand the difference between a drug and this therapy that activates the natural t-cell response.
Patience, not news, is what we need around here. This is no longer a flipping stock imo. Zhabilov has already been screwed by the SEC one time. He is not going to allow frivolous PRs meant to do nothing but prop up the stock price imo.
I hope we sit here until the Mexican Hospitals have signed their agreements and then it will be "unleash the hounds" time. If that means we go to no bid and the flippers all go elsewhere I would be thrilled. I would love to buy more at .0001 (my average).
yes, the share structure is going to be 2.2 billion in the O/S imo. The rest will be restricted. The share price may stay pretty much the same until a PR is released showing revenue is real and forthcoming. It is going to rocket the share price. If you don't want to wait then you should sell imo.
J/K...I still have all my .0001s and I am holding for at least a month no matter what happens. This stock will go over .02 at some point this year in my opinion.
lol, famous last words. VFIN is back.
the price doesn't matter right now. From the outside looking in, this looks like a scam stock that is a dilutive pig. Once I did my due diligence I realized that this should be over 2 cents.
When the PR hits about the Hospitals implementing this therapy (I think within 30 days), people will realize how explosive this stock is. Until then, accumulate and wait imo. This is going to be a story stock.
yep, doctors are now using coding on the genetic level to break the barrier that cancer tumors produce so your t-cells can go to work. The t-cells have a memory and once they are "taught" to attack cancer cells then the t-cells replicate and fight cancer for as long as you live.
This is the essence of Zhabilov's patent.
There is no change. I don't think we will see .0002 again and we will see the next wave now. I am holding all my .0001s for pennies.
I think you are being smart by noting we may not see anything else until mid-June. I doubt I will even watch this next week (I have too much work to do).
I have set a google alert so if anything big happens, the search engine will shoot me an email so I can watch it unfold.
Easy Longhorns1..BSSP has nothing to do with HIV. This is only for the cancer application and only in Mexico.
I for one think you guys at IMMB were HOSED by the SEC. I read their ruling and their final disposition and if I were an IMMB investor I would be very upset. My anger though would be directed at the real problem- SEC officials that overstepped their bounds. Oppressive government SUCKS.
Zhabilov is not going to put out PRs for the sake up supporting the stock price. The SEC has already hosed him one time when IMMB was at 10 cents.
When the Hospitals (that have already been targeted and imo have used this therapy in the past) sign up to provide the cancer immunotherapy, then this stock will fly. I would not be concerned unless I fail to see this PR by the middle of June.
Those who will relax and park their money here for 30 (most likely 20 days) are going to be richly rewarded imo.
Patience is key- who can wait one month? This therapy costs about 50,000 according to the hospital that offered this immunotherapy last year.
BSSP will get a significant chunk of that money. If this is a 10 million dollar company based on the maximum OS possible, then the share price will have a fair valuation of .0036.
Hell, the patent is worth ten million, so we could make an argument that we should be sitting at .0036 with no revenue. Now, add in revenue and folks should be able to see why this is going to pennies.
This immunotherapy has already been proven to work on cancer and hiv. Remember, it was a hospital in Bulgaria that paid for the EU trials on behalf of the company. That is how much promise the hospital saw in the patent for HIV.
Have a bit of patience- this is going to pennies.
BSSP volume now 125 million.
NITE w/ 146 million on bid. Same money as 420 million on bid at .0001.
smart flippers...sell half now and ride free shares...can't blame them.
BSSP- volume alert- big blocks going now.
BSSP- volume alert- 51 million already.
2 blocks of 10 million shares printed....nice.
CDEL and NITE run the show here. When CDEL is pushing the bid, this stock price is going up.
Trader, look at money flow on your chart. That tells the story here. This stock is dead in the water. The 10k will be the coup de grace.
BSSP- cancer immunotherapy reverse merger. The patent is worth 10 million and this stock is going over a penny when the hospitals licenses are announced imo.